Local excision vs. radical resection in T1-2 rectal carcinoma: Results of a study from the surveillance, epidemiology, and end results (SEER) registry data

Gastrointestinal Cancer Research

Volumn 3, Issue 3, 2009, Pages 105-114

  Hazard, Lisa J ^a   Sklow, Bradford ^a   Pappas, Lisa ^a   Boucher, Kenneth M ^a   Shrieve, Dennis C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYPECTOMY; POSTOPERATIVE CARE; RADICAL RESECTION; RECTUM CARCINOMA; RECTUM RESECTION; TUMOR VOLUME;

EID: 77953411045     PISSN: 19347820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Steele GJ, Herndon JE, Bleday R, et al: Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 6:433-441, 1999
2. Chorost M, Weber TK, Lee RJ, et al: Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg 179:271-274, 2000
3. Lee W, Lee D, Choi S, et al: Transanal endoscopic microsurgery and radical surgery for T1 and T2 rectal cancer. Surg Endosc 17:1283-1287, 2003
4. Neal D, Williams NS, Johnston D: A prospective study of bladder function before and after sphincter-saving resections for low carcinoma of the rectum. Br J Urol 53:558-564, 1981
5. Smith LE, Ko ST, Saclarides T, et al: Transanal endoscopic microsurgery. Initial registry results. Dis Colon Rectum 39(suppl10):S79-84, 1996
6. Surveillance Research Program N: Available from: http://seer.cancer.gov/ data/, 2007
7. American Joint Commitee on Cancer Staging Manual. (5th ed). Philadelphia: Lippincott-Raven; 1997
8. http://seer.cancer.gov/manuals/historic/codeman_1988.pdf.
9. Cox D: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
10. Engel J, Kerr J, Schlesinger-Raab A, et al: Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 238:203-213, 2003
11. Kim NK, Aahn TW, Park JK, et al: Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer. Dis Colon Rectum 45:1178-1185, 2002
12. You Y, Baxter NN, Stewart A, et al: Is the increasing rate of local excision for stage I rectal cancer in the United States justified? a nationwide cohort study from the National Cancer Database. Ann Surg 245:726-733, 2007
13. Russell AH, Harris J, Rosenberg PJ, et al: Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys 46:313-322, 2000
14. Grumann M, Noack EM, Hoffmann IA, et al: Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 233:149-156, 2001
15. Bentrem D, Okabe S, Wong WD, et al: T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg 242:472-477, 2005
16. Endreseth B, Myrvold HE, Romundstad P, et al: Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum 48:1380-1388, 2005
17. Nascimbeni R, Nivatvongs S, Larson DR, et al: Long-term survival after local excision for T1 carcinoma of the rectum. Dis Colon Rectum 47:1773-1779, 2004
18. Mellgren A, Sirivongs P, Rothenberger DA, et al: Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum 43:1064-1074, 2000
19. Brodsky JT, Richard GK, Cohen AM, et al: Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 69: 322-326, 1992
20. Chakravarti A, Compton CC, Shellito PC, et al: Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg 230:49-54, 1999
21. Willett CG, Compton CC, Shellito PC, et al: Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. Cancer 73:2716-2720, 1994
22. Fang WL, Chang SC, Lin JK, et al: Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterology 52:1688-1691, 2005
23. Landmann RG, Wong WD, Hoepfl J, et al: Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum 50:1520-1525, 2007
24. Thaler W, Watzka S, Martin F, et al: Preoperative staging of rectal cancer by endoluminal ultrasound vs. magnetic resonance imaging. Preliminary results of a prospective, comparative study. Dis Colon Rectum 37:1189-1193, 1994
25. Takahashi T, Ueno M, Azekura K, et al: Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 43(suppl 10):S59-S68, 2000
26. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646, 2001
27. Smith L, Ko ST, Saclarides T, et al: Transanal endoscopic microsurgery. Initial registry results. Dis Colon Rectum 39(suppl 10):S79-S84, 1996
28. Min BS, Kim NK, Ko YT, et al: Long-term oncologic results of patients with distal rectal cancer treated by local excision with or without adjuvant treatment. Int J Colorectal Dis 22:1325-1330, 2007
29. Chorost M, Petrelli NJ, McKenna M, et al: Local excision of rectal carcinoma. Am Surg 67: 774-779, 2001
30. Varma MG, Rogers SJ, Schrock TR, et al: Local excision of rectal carcinoma. Arch Surg 134:863-868, 1999
31. Birgisson H, Pahlman L, Gunnarsson U, et al: Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23:8697-8705, 2005
32. Haddock MG, Sloan JA, Bollinger JW, et al: Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial. J Clin Oncol 25:1255-1259, 2007
33. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
34. Lezoche E, Guerrieri M, Paganini AM, et al: Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg 92:1546-1552, 2005
35. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 1991
36. Rodel C, Liersch T, Hermann RM, et al: Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 25:110-117, 2007
37. Willeke F, Horisberger K, Kraus-Tiefenbacher U, et al: A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer. Br J Cancer 96:912-917, 2007
38. Czito BG, Bendell JC, Willett CG, et al: Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: phase I trial results. Int J Radiat Oncol Biol Phys 68:472-478, 2007
39. Atkin WS, Morson BC, Cuzick J: Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326:658-662, 1992